Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura
Ligand and Neurogen Amend Merger Agreement
Ligand Presents New Preclinical Data on its Lead SARM Molecule LGD-4033 at the Gerontological Society of America Annual Meeting
Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc.
Ligand Pharmaceuticals Announces Third Quarter Results
Ligand's JAK3 Research Collaboration Extended by Pfizer
Ligand Updates License Agreement with Exelixis
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Ligand to Hold Third Quarter Results Conference Call on November 5
PROMACTA Awarded 2009 Prix Galien for Best Biotechnology Product
Ligand to Present on October 6th at the Fourth Annual JMP Securities Healthcare Focus Conference
Ligand and GlaxoSmithKline Collaboration Identifies New Compound
Ligand Presents to Investors at Thomas Weisel Partners Healthcare Conference
Ligand to Present at Thomas Weisel Partners on September 9
